Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06294886 · ClinicalTrials.gov registry record
Vaginal Fluid Collection for Detection of Endometrial Cancer
A clinical trial of Endometrial Cancer, sponsored by Innovis.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06294886: Recruiting study of Endometrial Cancer, sponsored by Innovis.
NCT06294886 is a study of Endometrial Cancer that is actively recruiting participants, run by Innovis. The registered enrollment target is 40 participants, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06294886, a study of Endometrial Cancer, is actively recruiting participants, sponsored by Innovis.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to obtain de-identified vaginal fluid specimens from participants with an endometrial tissue biopsy-based histopathological diagnosis of endometrial cancer (EC), endometrial hyperplasia (AEH) with atypia or endometrial intraepithelial neoplasia (EIN). The samples will be used for the purpose of research and development of a new molecular diagnostic test for the detection of EC, AEH and EIN.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Screening test to detect endometrial cancer and precancer
Study Locations (1)
Louisiana
- Trials365 - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-02-19 |
| Est. Completion | 2024-06-01 |
What NCT06294886 shows while recruiting
NCT06294886 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Screening test to detect endometrial cancer and precancer is the first listed.
NCT06294886 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT06294886 about?
NCT06294886 is a clinical study titled "Vaginal Fluid Collection for Detection of Endometrial Cancer". The primary objective of this study is to obtain de-identified vaginal fluid specimens from participants with an endometrial tissue biopsy-based histopathological diagnosis of endometrial cancer (EC), endometrial hyperplasia (AEH) with atypia or endometrial intraepithelial neoplasia (EIN). The samp...
What is the current status of trial NCT06294886?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-02-19. Estimated completion is 2024-06-01.
What conditions does trial NCT06294886 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT06294886?
The interventions under investigation include: Screening test to detect endometrial cancer and precancer (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06294886?
This trial is sponsored by Innovis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06294886 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06294886's enrollment target sits among peer trials
40 137th of 181 higher than 44 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI